Navigation path

Additional tools



    Profile of registrant

International Drug Policy Consortium

Identification number in the register: 75318797051-52
Registration date: 01/11/2011 17:02:21

The information on this entity was last modified on: 30/03/2015 15:03:26
The date of the last annual update was: 30/03/2015 15:03:26
Next update due latest on: 30/03/2016

    Registrant : Organisation or self-employed individual

International Drug Policy Consortium

IDPC

Company limited by guarantee

    Section of registration

III - Non-governmental organisations

Non-governmental organisations, platforms and networks and similar

    Contact details

5th Floor
124-128 City Road
London EC1V 2NJ
UNITED KINGDOM

(+44) 2073242975

    Person with legal responsibility

Ms  Ann Fordham

Executive Director

    Person in charge of EU relations

Ms  Ann Fordham

Executive Director

    Goals / remit

IDPC is a a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC produces briefing papers, disseminates the reports of its member organisations about particular drug-related matters, and offers expert advice to policy makers and officials around the world.

IDPC members have a wide range of experience and expertise in the analysis of drug problems and policies, and have contributed to policy debates at national and international level.

We have two main objectives:
- We provide channels for grassroots organisations to better engage with policy making processes: we facilitate communication and cooperation between civil society stakeholders, and we produce and disseminate information and materials on more effective and humane drug policies, that national and local NGOs can use in their own work. We also organise capacity building trainings to support the drug policy advocacy work of NGOs. In order to facilitate civil society engagement, we organise our work regionally.

- We draw on the knowledge within our network to offer expert advice to policy makers on how best to review their drug policies at the national and international level. The IDPC network includes many individuals who have experience of creating or reviewing government drug policies and strategies, and these individuals are available to engage in high-level discussions with policy makers.

  • European
  • global
  • national

    Specific activities covered by the Register

IDPC is part of the Civil Society Forum on Drugs. As such, we engage directly in activities aimed at advising and providing recommendations to EU institutions around drug policy issues. We also collaborate with partners to organise seminars and discussions on European drug policies, in particular in the lead up to the 2016 United Nations General Assembly Special Session on drugs.


 

No

No

European Civil Society Forum on Drugs/

No

No

Over the past three years, under grants from the European Commission Drug Prevention and Information Programme, IDPC conducted a number of activities across Europe, in collaboration with key NGO partners.

In 2010-2011, IDPC supported the creation of a dynamic network of NGOs from South East Europe to promote exchange of information and experience among professionals in the field of drug policy in the region. We also produced a number of publications focused on South East Europe and Western European countries.

Since April 2011, IDPC has been involved in a project funded by the European Commission in collaboration with the Transnational Institute and other European NGOs. This project aims to promote exchange of experience through informal drug policy dialogues, expert seminars and the drafting of expert publications on issues related to the European Union and European countries.

IDPC also shares evidence and best practice from the EU and its member states in international forums, such as the Commission on Narcotic Drugs (CND), through the organisation of side events, the dissemination of materials and direct meetings with government delegations.

IDPC is also an active member of the European Commission Civil Society Forum on Drugs where we have engaged in drug policy debates regarding the European Union Drug Strategy and its Action Plans.

Individually, IDPC has also watched closely the drafting of the new EU Drug Strategy for 2013-2020 and the Action Plan for 2013-2016. We have provided a set of recommendations, as well as organised a seminar at the European Parliament in May 2012 to ensure open discussions among representatives of EU institutions and international experts on the direction of EU drug policy for the coming years.

IDPC regularly offers recommendations to the European Commission, in particular the Horizontal Drugs Group, on key aspects of European Drug Policy and strategic positions in the lead up to the United Nations General Assembly Special Session on Drugs (UNGASS) to be held in 2016.

    Number of persons involved in the activities described in the box above

100%: 4   25%: 1

5

4.2

IDPC staff includes four full time and one part-time staff members. We also hire consultants around the world who work on thematic or regional issues related to drug policy. For more information on the IDPC team, please visit: www.idpc.net/team.

    Persons accredited for access to European Parliament premises

No accredited persons

    Fields of interest

  • Communication
  • Development
  • External Relations
  • Home Affairs
  • Justice and Fundamental Rights
  • Public Health
  • Regional Policy
  • Trans-European Networks
  • Youth

    Membership and affiliation

132

The full list of our members per region is available here: http://idpc.net/members

  • BELGIUM
  • BULGARIA
  • CROATIA
  • DENMARK
  • FRANCE
  • GERMANY
  • GREECE
  • HUNGARY
  • IRELAND
  • ITALY
  • LITHUANIA
  • NETHERLANDS
  • POLAND
  • PORTUGAL
  • ROMANIA
  • SLOVENIA
  • SPAIN
  • SWEDEN
  • UNITED KINGDOM
  • ALBANIA
  • ARGENTINA
  • AUSTRALIA
  • BOLIVIA
  • BOSNIA-HERZEGOVINA
  • BRAZIL
  • CANADA
  • CHILE
  • COLOMBIA
  • COSTA RICA
  • DOMINICAN REPUBLIC
  • EL SALVADOR
  • GEORGIA
  • INDIA
  • INDONESIA
  • KENYA
  • LEBANON
  • LIBERIA
  • MACEDONIA, FORMER YUGOSLAV REPUBLIC OF
  • MALAYSIA
  • MAURITIUS
  • MEXICO
  • MONTENEGRO
  • NEW ZEALAND
  • PALESTINIAN OCCUPIED TERRITORY
  • PERU
  • PHILIPPINES
  • PUERTO RICO
  • RUSSIA, FEDERATION OF
  • SAINT LUCIA
  • SENEGAL
  • SERBIA
  • SWITZERLAND
  • THAILAND
  • TUNISIA
  • TURKEY
  • UGANDA
  • UNITED ARAB EMIRATES
  • UNITED STATES
  • URUGUAY
  • VIETNAM
  • ZIMBABWE

IDPC is a member of the European Civil Society Forum on Drugs, of the Vienna NGO Committee on Drugs, and of the New York NGO Committee on Drugs. IDPC also has ECOSOC Consultative Status.

    Financial data

04/2013  -  03/2014

< 9,999 €

963,781 €

364,645 €

 €

126,753 €

European Drug Prevention and Information Program

237,892 €

599,136 €

599,136 €

    Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.